Trinity Biotech reported $-17.48M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Bayer EUR 2.76B 6.52B Mar/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
EDAP TMS EUR -9.08M 4.07M Mar/2026
J&J USD 5.53B 299M Jun/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
OraSure Technologies USD -19.29M 5.57M Dec/2025
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Siemens EUR 2.27B 243M Jun/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Tosoh JPY 19.46B 2.47B Jun/2026
Trinity Biotech USD -17.48M 12.34M Dec/2025
Veracyte USD 25.49M 3.22M Jun/2026